CD226 and neoplasm: In contrast to delayed tumor progression in TIGIT-/- and CD96-/-, CD226-deficient mice exhibit increased susceptibility to MCA-induced fibrosarcomas as well as metastatic lung colonization (e.g., LLC lung and RM-1 prostate tumors) (19, 20, 56–58).